title: Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study.
abstract: Metal-on-metal bearings are being increasingly used in young patients. The potential adverse effects of systemic metal ion elevation are the subject of ongoing investigation. The purpose of this study was to investigate whether cobalt and chromium ions cross the placenta of pregnant women with a metal-on-metal hip resurfacing and reach the developing fetus. Whole blood levels were estimated using high-resolution inductively-coupled plasma mass spectrometry. Our findings showed that cobalt and chromium are able to cross the placenta in the study patients with metal-on-metal hip resurfacings and in control subjects without any metal implants. In the study group the mean concentrations of cobalt and chromium in the maternal blood were 1.39 microg/l (0.55 to 2.55) and 1.28 microg/l (0.52 to 2.39), respectively. The mean umbilical cord blood concentrations of cobalt and chromium were comparatively lower, at 0.839 microg/l (0.42 to 1.75) and 0.378 microg/l (0.14 to 1.03), respectively, and this difference was significant with respect to chromium (p < 0.05). In the control group, the mean concentrations of cobalt and chromium in the maternal blood were 0.341 microg/l (0.18 to 0.54) and 0.199 microg/l (0.12 to 0.33), and in the umbilical cord blood they were 0.336 microg/l (0.17 to 0.5) and 0.194 microg/l (0.11 to 0.56), respectively. The differences between the maternal and umbilical cord blood levels in the controls were marginal, and not statistically significant (p > 0.05). The mean cord blood level of cobalt in the study patients was significantly greater than that in the control group (p < 0.01). Although the mean umbilical cord blood chromium level was nearly twice as high in the study patients (0.378 microg/l) as in the controls (0.1934 microg/l), this difference was not statistically significant. (p > 0.05) The transplacental transfer rate was in excess of 95% in the controls for both metals, but only 29% for chromium and 60% for cobalt in study patients, suggesting that the placenta exerts a modulatory effect on the rate of metal ion transfer.
authors.affiliation: The McMinn Centre, 25, Highfield Road, Birmingham, UK.
authors.forename: H
authors.initials: H
authors.lastname: Ziaee
authors.forename: J
authors.initials: J
authors.lastname: Daniel
authors.forename: A K
authors.initials: AK
authors.lastname: Datta
authors.forename: S
authors.initials: S
authors.lastname: Blunt
authors.forename: D J W
authors.initials: DJ
authors.lastname: McMinn
mesh_terms: D000328:Adult; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D016022:Case-Control Studies; D002857:Chromium / Q000097:blood*; D003035:Cobalt / Q000097:blood*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006622:Hip Prosthesis; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D011247:Pregnancy; D011446:Prospective Studies; D011474:Prosthesis Design
chemical_list: D002857:Chromium; D003035:Cobalt